search
Back to results

ORI2 : ORI for hyperOxia Reduction in ICU (ORI2)

Primary Purpose

Intensive Care Units

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
monitoring with ORI + SpO2
monitoring with SpO2
Sponsored by
University Hospital, Angers
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Intensive Care Units focused on measuring HYPEROXIA, MECHANICAL VENTILATION, OXYGEN RESERVE INDEX

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient hospitalized in ICU of Angers hospital
  • Patient intubated and mechanically ventilated for an expected period of at least 2 days

Inclusion is to achieve within 6 hours after admission (for admitted patients intubated ) or at the time of intubation (for non- intubated patients on admission )

Exclusion Criteria:

  • Pregnant Woman

Sites / Locations

  • Chu Angers

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

monitoring with ORI + SpO2

monitoring with SpO2

Arm Description

Patients receive the regular monitoring with SpO2, but in this group, the ORI parameters is shown on the scope. Lower and upper SpO2 limits are prescribed for each patient.

Patients receive the regular monitoring; the ORI parameters is not shown (but it is recorded each time a blood gas is drown). Lower and upper SpO2 limits are prescribed for each patient.

Outcomes

Primary Outcome Measures

Percentage of days with moderate hyperoxia
The primary endpoint is the percentage of days with moderate hyperoxia. Moderate hyperoxia is defined by a PaO2> 100 mmHg - measured on blood gases obtained in usual practicePaO2 will be followed by the inclusion until the end of mechanical ventilation or D28 or ICU discharge. The percentage of days with moderate hyperoxia is (number of days of moderate hyperoxia / number of days of oxygen therapy) x100. The follow up will occurs from inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge

Secondary Outcome Measures

Minimum and maximum daily FiO2
The secondary endpoints are the minimum and maximum daily FiO2, obtained by respirator in each group. FiO2 will be followed by the inclusion until the end of oxygenotherapy or D28.
Minimum and maximum daily PaO2
The secondary endpoints are the minimum and maximum daily PaO2, (measured by blood gases obtained in usual practice ) . PaO2 will be followed by the inclusion until the end of oxygenotherapy or D28.
Length of mechanical ventilation
The secondary endpoint is the length of mechanical ventilation, (unit: day number)
Number of day with PaO2 equal or above to 80 mmHg
The secondary endpoint is the number of the day where patient is mechanically ventilated and has a PaO2 equal or above to 100 mmHg and 80 mmHg . PaO2 is measured by blood gases obtained in usual practice . this outcome will be followed by the inclusion until the end of mechanical ventilation or D28.
Number of hypoxemia episode
The secondary endpoint is the number (in day) of hypoxemia (defined by PaO2<60 mmHg - measured by blood gases obtained in usual practice). PaO2 will be followed by the inclusion until the end of oxygenotherapy or D28.
Number of day without mechanical ventilation at D28
The secondary endpoint is the number of day without mechanical ventilation at D28. It will be followed by the inclusion until D28.
Number of atelectasis episodes requiring specific medical care (that means fibro-aspiration or posture of patient)
The secondary endpoint is the number of atelectasis episodes requiring specific medical care. It will be followed by the inclusion until the end of mechanical ventilation or D28.
Average daily PaO2
The primary endpoint is the average daily PaO 2 in each group (measured by blood gases obtained in usual practice ) . PaO2 will be followed by the inclusion until the end of oxygenotherapy or D28.
Number of moderate hypoxemia hours
this outcomes follows the formula: Moderate hypoxia (in hours) = a + b. With a = the sum of the durations (in hours) between two GDS having a PaO2> 100mmHg and b = the sum of the half times (in hours) between a GDS having a PaO2> 100mmHg and a GDS having a PaO2 ≤ 100mmHg
Maximum ORI values during pre-oxygenation before a endotracheal aspiration
The secondary endpoint is the maximum ORI values during pre-oxygenation before a endotracheal aspiration
Minimum SpO2 within 15 minutes following a endotracheal aspiration
The primary endpoint is the minimum SpO2 within 15 minutes following a endotracheal aspiration, with or without recruitment maneuver.

Full Information

First Posted
August 22, 2016
Last Updated
November 15, 2020
Sponsor
University Hospital, Angers
search

1. Study Identification

Unique Protocol Identification Number
NCT02878460
Brief Title
ORI2 : ORI for hyperOxia Reduction in ICU
Acronym
ORI2
Official Title
ORI2 : ORI for hyperOxia Reduction in ICU
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
April 27, 2017 (Actual)
Primary Completion Date
May 22, 2018 (Actual)
Study Completion Date
May 22, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Angers

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Recently, hyperoxia has been recognized as being potentially deleterious for critically ill patients, with increased duration of mechanical ventilation and even with increased mortality rates. This could be related to pulmonary lesions (including notably atelectasis) but also to increased tissue damage and organ dysfunctions, secondary to increased/induced oxidative stress. At last higher FiO2 led to "over-consumption" of oxygen and therefore to additional costs. Usually, FiO2 and oxygen flows are modified according to the monitoring of SpO2. But, it has also been recognized that modifying FiO2 (and oxygen flows) according to SpO2 monitoring is not routinely (or easily) done. Indeed, nurses (and doctors) are reluctant to reduce oxygen flows when everything appear under control. The ORI (Oxygen Reserve Index) is an index measured using non-invasive SpO2 sensors (Rainbow sensors- MASIMO) that evaluates non-invasively PaO2 (partial pressure of oxygen). An ORI ≤0 indicates that PaO2 is less than 100 mmHg. When ORI increases (i.e. ORI≥0.01) PaO2 is higher than 100 mmHg. This index increases up to 1. ORI between 0.01 and 1 indicates that PaO2 is probably between 100 and 200 mmHg. Thus, monitoring critically ill patients using the ORI, may help identifying when PaO2 is high and when FiO2 (or oxygen flows in non-intubated patients) may be reduced. This could help reducing the time with hyperoxia (i.e. PaO2 ≥100 mmHg or ≥80 mmHg). The purpose of this feasibility study is to evaluate if the use of ORI can help to decrease length of moderate hyperoxia (PaO2>100mmHg) in critically ill patients, in comparison with monitoring the SpO2 only.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intensive Care Units
Keywords
HYPEROXIA, MECHANICAL VENTILATION, OXYGEN RESERVE INDEX

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
150 (Actual)

8. Arms, Groups, and Interventions

Arm Title
monitoring with ORI + SpO2
Arm Type
Experimental
Arm Description
Patients receive the regular monitoring with SpO2, but in this group, the ORI parameters is shown on the scope. Lower and upper SpO2 limits are prescribed for each patient.
Arm Title
monitoring with SpO2
Arm Type
Other
Arm Description
Patients receive the regular monitoring; the ORI parameters is not shown (but it is recorded each time a blood gas is drown). Lower and upper SpO2 limits are prescribed for each patient.
Intervention Type
Other
Intervention Name(s)
monitoring with ORI + SpO2
Other Intervention Name(s)
ORI group
Intervention Description
If ORI is equal to 0.00, the FiO2 (or oxygen flow) is not changed. if ORI is ≥ 0.01, Nurses must decrease the FiO2 (or oxygen flow) by 10%, until ORI is =0. if SpO2 is < lower individualized limit, FiO2 (or oxygen flow) is increased by 10%, if it happens twice, doctors are called.
Intervention Type
Other
Intervention Name(s)
monitoring with SpO2
Other Intervention Name(s)
Control group
Intervention Description
If SpO2 is below the upper individualized limit, the FiO2 (or oxygen flow) is not changed. If SpO2 is equal or above this limit, Nurses must reduce the FiO2 (or oxygen flow) by 10% every 10 minutes until SpO2 is ≤ upper individualized limit, with FiO2≥25 %. if SpO2 is < lower individualized limit, FiO2 (or oxygen flow) is increased by 10%, if it happens twice, doctors are called.
Primary Outcome Measure Information:
Title
Percentage of days with moderate hyperoxia
Description
The primary endpoint is the percentage of days with moderate hyperoxia. Moderate hyperoxia is defined by a PaO2> 100 mmHg - measured on blood gases obtained in usual practicePaO2 will be followed by the inclusion until the end of mechanical ventilation or D28 or ICU discharge. The percentage of days with moderate hyperoxia is (number of days of moderate hyperoxia / number of days of oxygen therapy) x100. The follow up will occurs from inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge
Time Frame
inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge
Secondary Outcome Measure Information:
Title
Minimum and maximum daily FiO2
Description
The secondary endpoints are the minimum and maximum daily FiO2, obtained by respirator in each group. FiO2 will be followed by the inclusion until the end of oxygenotherapy or D28.
Time Frame
inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge
Title
Minimum and maximum daily PaO2
Description
The secondary endpoints are the minimum and maximum daily PaO2, (measured by blood gases obtained in usual practice ) . PaO2 will be followed by the inclusion until the end of oxygenotherapy or D28.
Time Frame
inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge
Title
Length of mechanical ventilation
Description
The secondary endpoint is the length of mechanical ventilation, (unit: day number)
Time Frame
inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge
Title
Number of day with PaO2 equal or above to 80 mmHg
Description
The secondary endpoint is the number of the day where patient is mechanically ventilated and has a PaO2 equal or above to 100 mmHg and 80 mmHg . PaO2 is measured by blood gases obtained in usual practice . this outcome will be followed by the inclusion until the end of mechanical ventilation or D28.
Time Frame
inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge
Title
Number of hypoxemia episode
Description
The secondary endpoint is the number (in day) of hypoxemia (defined by PaO2<60 mmHg - measured by blood gases obtained in usual practice). PaO2 will be followed by the inclusion until the end of oxygenotherapy or D28.
Time Frame
inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge
Title
Number of day without mechanical ventilation at D28
Description
The secondary endpoint is the number of day without mechanical ventilation at D28. It will be followed by the inclusion until D28.
Time Frame
inclusion to D28
Title
Number of atelectasis episodes requiring specific medical care (that means fibro-aspiration or posture of patient)
Description
The secondary endpoint is the number of atelectasis episodes requiring specific medical care. It will be followed by the inclusion until the end of mechanical ventilation or D28.
Time Frame
inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge
Title
Average daily PaO2
Description
The primary endpoint is the average daily PaO 2 in each group (measured by blood gases obtained in usual practice ) . PaO2 will be followed by the inclusion until the end of oxygenotherapy or D28.
Time Frame
inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge
Title
Number of moderate hypoxemia hours
Description
this outcomes follows the formula: Moderate hypoxia (in hours) = a + b. With a = the sum of the durations (in hours) between two GDS having a PaO2> 100mmHg and b = the sum of the half times (in hours) between a GDS having a PaO2> 100mmHg and a GDS having a PaO2 ≤ 100mmHg
Time Frame
inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge
Title
Maximum ORI values during pre-oxygenation before a endotracheal aspiration
Description
The secondary endpoint is the maximum ORI values during pre-oxygenation before a endotracheal aspiration
Time Frame
At each pre-oxugenation before a endotracheal aspiration occurs from inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge
Title
Minimum SpO2 within 15 minutes following a endotracheal aspiration
Description
The primary endpoint is the minimum SpO2 within 15 minutes following a endotracheal aspiration, with or without recruitment maneuver.
Time Frame
At each endotracheal aspiration occurs from inclusion to the end of mechanical ventilation or Day 28 if patient is still mechanically ventilated or ICU discharge

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient hospitalized in ICU of Angers hospital Patient intubated and mechanically ventilated for an expected period of at least 2 days Inclusion is to achieve within 6 hours after admission (for admitted patients intubated ) or at the time of intubation (for non- intubated patients on admission ) Exclusion Criteria: Pregnant Woman
Facility Information:
Facility Name
Chu Angers
City
Angers
ZIP/Postal Code
49000
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31410497
Citation
Lasocki S, Brochant A, Leger M, Gaillard T, Lemarie P, Gergaud S, Dupre P. ORI monitoring allows a reduction of time with hyperoxia in critically ill patients: the randomized control ORI2 study. Intensive Care Med. 2019 Nov;45(11):1661-1662. doi: 10.1007/s00134-019-05732-9. Epub 2019 Aug 13. No abstract available.
Results Reference
result

Learn more about this trial

ORI2 : ORI for hyperOxia Reduction in ICU

We'll reach out to this number within 24 hrs